O'Brien Greene & Co. Inc Becton Dickinson & CO Transaction History
O'Brien Greene & Co. Inc
- $291 Million
- Q4 2024
A detailed history of O'Brien Greene & Co. Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 5,918 shares of BDX stock, worth $1.35 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
5,918
Previous 22,740
73.98%
Holding current value
$1.35 Million
Previous $5.48 Million
75.52%
% of portfolio
0.46%
Previous 1.8%
Shares
26 transactions
Others Institutions Holding BDX
# of Institutions
1,800Shares Held
260MCall Options Held
1.27MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA26.7MShares$6.08 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$5.06 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$3.2 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.81 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.76 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $64.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...